Skip to main content

Table 1 Clinical characteristics in the study population

From: Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome

Variables

Rupture

Non-rupture

P value

n

49

95

 

Age (years)

59 ± 9

60 ± 10

0.474

Males

28 (57.1)

62 (65.3)

0.340

Current smoking

34 (69.4)

51 (53.7)

0.069

Hypertension

36 (73.5)

65 (68.4)

0.531

Hyperlipidemia

32 (65.3)

58 (61.1)

0.617

Duration of diabetes (years)

4.2 (2.0, 5.2)

2.5 (1.2, 4.8)

0.009

BMI (kg/m2)

26.4 ± 3.6

25.6 ± 3.5

0.110

LVEF (%)

59.5 ± 8.3

62.2 ± 9.2

0.092

eGFR (mL/min/1.73 m2)

84.6 ± 28.6

88.0 ± 30.8

0.491

SBP (mmHg)

130 ± 13

131 ± 16

0.612

DBP (mmHg)

76 ± 8

77 ± 10

0.638

TG (mmol/L)

1.93 (1.12, 2.13)

1.72 (0.94, 1.88)

0.079

HDL-C (mmol/L)

0.96 (0.82, 1.24)

1.02 (0.91, 1.23)

0.314

Non-HDL-C (mmol/L)

4.39 (3.63, 4.99)

3.83 (3.43, 4.36)

0.006

WBC (109/L)

7.3 ± 1.6

7.2 ± 1.7

0.958

hs-CRP (mg/dL)

2.46 (1.61, 5.23)

1.22 (0.84, 4.01)

0.014

NT-proBNP

390 (155, 960)

362 (105, 890)

0.413

TnI

1.20 (0.11, 5.12)

0.91 (0.03, 2.62)

0.228

Urinary 8-iso-PGF (pmol/mmolCr)

141.9 ± 67.2

116.1 ± 71.6

0.038

FBG (mmol/L)

8.1 ± 3.0

7.1 ± 2.0

0.023

HbA1c (%)

7.2 ± 0.5

7.0 ± 0.6

0.025

1,5-AG (µg/mL)

10.5 ± 5.5

14.1 ± 7.7

0.005

Medications on admission

   

 Aspirin

36 (73.5)

71 (74.7)

0.869

 Statins

27 (55.1)

62 (65.3)

0.234

 ACEI/ARB

25 (51.0)

52 (54.7)

0.672

 Oral antidiabetic drugs

31 (63.3)

64 (67.4)

0.622

 Insulin

16 (32.7)

32 (33.7)

0.901

  1. Data are given as number (percentage) for categorical variables and mean ± standard deviation or median (IQR) for continuous variables
  2. BMI body mass index, LVEF left ventricular ejection fraction, eGFR estimated glomerular filtration rate, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, HDL-C high-density lipoprotein cholesterol, non-HDL-C non-high-density lipoprotein cholesterol, WBC white blood cell, hs-CRP high-sensitivity C-reactive protein, NT-proBNP N-terminal pro-brain natriuretic peptide, TnI troponin I, 8-iso-PGF 8-iso-prostaglandin F, FBG fasting blood glucose, HbA1c hemoglobin A1c, 1,5-AG 1,5-anhydroglucitol, ACEI/ARB angiotensin-converting-enzyme inhibitor/angiotensin II receptor blocker